Oncology Med Enters Into Letter of Intent to Acquire Medical/Radiation Company Which Has Gross Revenues of $2,800,000.00

PITTSBURGH, PA--(Marketwire - January 30, 2008) - Oncology Med, Inc. (PINKSHEETS: ONCO) a Pittsburgh based cancer treatment solutions group, announced today that it has entered into a letter of intent to acquire a synergistic company in the field of physics and radiation that has annual revenues of $2,800,000.00, operates on a national scale, and is profitable. Upon the closing of this acquisition, which is subject to due diligence review by both parties and the execution of definitive agreements of purchase, the combined entity will have an annual revenue run rate of $5,000,000.00. The Company is prevented from announcing the name of the acquisition candidate until the completion of the due diligence period and execution of a definitive agreement of purchase.